Rockwell Medical, Inc.

NASDAQ:RMTI

3.48 (USD) • At close October 21, 2024
Bedrijfsnaam Rockwell Medical, Inc.
Symbool RMTI
Munteenheid USD
Prijs 3.475
Beurswaarde 107,829,945
Dividendpercentage 0%
52-weken bereik 1.16 - 4.57
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Dr. Mark Strobeck Ph.D.
Website https://www.rockwellmed.com

An error occurred while fetching data.

Over Rockwell Medical, Inc.

Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iron therapy

Vergelijkbare Aandelen

Unicycive Therapeutics, Inc. logo

Unicycive Therapeutics, Inc.

UNCY

0.435 USD

Star Equity Holdings, Inc. logo

Star Equity Holdings, Inc.

STRR

4.024 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)